Franz B Humer insider trades

Open-market stock purchases and sales by Franz B Humer, Director at Allogene Therapeutics, Inc, from SEC Form 4 filings since Jul 1, 2012.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -88%.

Recent trades

DateStockTradeValue
Jun 18, 2026ALLO Allogene Therapeutics, IncBought (not open market)—

Companies traded

  • ALLO Allogene Therapeutics, Inc: 1 buy, 2 sales, last Jun 18, 2026
  • C Citigroup Inc: other filings, last Apr 1, 2019
  • KITE Kite Pharma, Inc: other filings, last Oct 3, 2017

Get free alerts when Franz B Humer files a new trade →